Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,810.00
+15.00 (0.40%)
At close: Feb 27, 2026
Market Cap82.84B +5.3%
Revenue (ttm)111.12B +11.4%
Net Income5.66B +3,670.1%
EPS150.83 +2,067.6%
Shares Out21.74M
PE Ratio25.26
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume84,354
Average Volume81,977
Open3,760.00
Previous Close3,795.00
Day's Range3,745.00 - 3,850.00
52-Week Range3,285.00 - 5,090.00
Beta0.52
RSI44.44
Earnings DateMar 17, 2026

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements